The treatment of diabetic foot infections: focus on ertapenem

References

• PecoraroREReiberGEBurgessEMPathways to diabetic limb amputation. Basis for preventionDiabetes Care1990135135212351029
   PubMed Web of Science ®Google Scholar
• BakkerKFosterAVMvan HoutoumWHInternational Diabetes Federation and International Working Group of the Diabetic Foot2005Time to Act. The Netherlands.
   Google Scholar
• ReiberGEEpidemiology of foot ulcers and amputations in the diabetic footBowkerJHPfeiferMALevin and O’Neal’s The Diabetic Foot6th EdMosbySt. Louis20011332
   Google Scholar
• LipskyBABerendtARGunner DeeryHDiagnosis and treatment of diabetic foot infectionsClin Infect Dis20043988591015472838
   PubMed Web of Science ®Google Scholar
• LipskyBAA report from the international consensus on diagnosing and treating the infected diabetic footDiabetes Metab Res Rev200420Suppl 1S68S7715150818
   PubMed Web of Science ®Google Scholar
• BerendtARPetersEJBakkerKDiabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatmentDiabetes Metab Res Rev200824Suppl 1S145S16118442163
   PubMedGoogle Scholar
• BerendtARPetersEJBakkerKSpecific guidelines for treatment of diabetic foot osteomyelitisDiabetes Metab Res Rev200824Suppl 1S190S19118442187
   PubMedGoogle Scholar
• LipskyBANew developments in diagnosing and treating diabetic foot infectionsDiabetes Metab Res Rev200824Suppl 1S66S7118395871
   PubMedGoogle Scholar
• LaveryLAArmstrongDGMurdochDPValidation of the infectious diseases society of America’s diabetic foot infection classification systemClin Infect Dis20074456256517243061
   PubMed Web of Science ®Google Scholar
• FrykbergRGZgonisTArmstrongDGDiabetic foot disorders: a clinical practice guidelineJ Foot Ankle Surg200645S2S66
   Google Scholar
• EdmondsMFosterASandersLPractical Manual of Diabetic Foot Care2nd edOxfordBlackwell2008
   Google Scholar
• CitronDMGoldsteinEJMerriamCVBacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agentsJ Clin Microbiol2007452819282817609322
   PubMed Web of Science ®Google Scholar
• DangCNPrasadYDMBoultonAJMMethicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problemDiabet Med200320215916312581269
   PubMedGoogle Scholar
• TentolourisNPetrikkosGVallianouNPrevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcersClin Microbiol Infect20061218618916441460
   PubMed Web of Science ®Google Scholar
• FerryTEtienneJCommunity acquired MRSA in EuropeBMJ200733594794817956927
   PubMedGoogle Scholar
• LentinoJRNaritaMYuVLNew antimicrobial agents as therapy for resistant gram-positive cocciEur J Clin Microbiol Infect Dis20082731517899228
   PubMed Web of Science ®Google Scholar
• LipskyBAItaniKNordenCLinezolid Diabetic Foot Infections Study GroupTreating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid vs ampicillin–sulbactam/amoxicillin–clavulanateClin Infect Dis200438172414679443
   PubMed Web of Science ®Google Scholar
• SteinGESchooleySPeloquinCALinezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infectionsAntimicrob Chemother200760819823
   Google Scholar
• LipskyBAStoutenburghULipskyBADaptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infectionsJ Antimicrob Chemother20055524024515659542
   PubMed Web of Science ®Google Scholar
• LegoutMAssalPRohnerPSevere Streptococcus agalactiae infection of the diabetic foot. A deleterious role of Streptococcus agalactiaePresse Med200534491494
   Google Scholar
• NelsonEAO’MearaSGolderSystematic review of antimicrobial treatments for diabetic foot ulcersDiabet Med20062334835916620262
   PubMed Web of Science ®Google Scholar
• NelsonEAO’MearaSCraigDA series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcersHealth Technol Assess200610iiiivixx1221
   Google Scholar
• LipskyBAEmpirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selectionClin Microbiol Infect20071335135317359317
   PubMed Web of Science ®Google Scholar
• BaderMSDiabetic foot infectionAm Fam Physician200878717918649613
   PubMed Web of Science ®Google Scholar
• ClayPGGrahamMRLindseyCCClinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with every 6 hours as empiric treatment for diabetic lower-extremity infections in older malesAm J Geriatr Pharmacother2004218118915561650
   PubMedGoogle Scholar
• LipskyBAArmstrongDGCitronDMErtapenem vs piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trialLancet20053661695170316291062
   PubMed Web of Science ®Google Scholar
• WeigeltJItaniKStevensDLinezolid CSSTI Study Group Linezolid vs vancomycin in treatment of complicated skin and soft tissue infectionsAntimicrob Agents Chemother2005492260226615917519
   PubMed Web of Science ®Google Scholar
• RybakMJThe efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteriaClin Microbiol Infect200612Suppl 1243216445721
   PubMed Web of Science ®Google Scholar
• EisensteinBILipopeptides, focusing on daptomycin, for the treatment of Gram-positive infectionsExpert Opin Investig Drugs20041311591169
   PubMed Web of Science ®Google Scholar
• DavisSLMcKinnonPSHallLMDaptomycin vs vancomycin for complicated skin and skin structure infections: clinical and economic outcomesPharmacotherapy200327121611161818041881
   PubMedGoogle Scholar
• SottoABouzigesNJourdanNIn vitro activity of tigecycline against strains isolated from diabetic foot ulcersPathol Biol (Paris)20075539840617905534
   PubMedGoogle Scholar
• LipskyBAGiordanoPChoudhriSTreating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanateJ Antimicrob Chemother20076037037617553812
   PubMed Web of Science ®Google Scholar
• RaymakersJTHoubenAJvan der HeydenJJThe effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limbDiabet Med20011822923411318845
   PubMed Web of Science ®Google Scholar
• HarklessLBoghossianJPollakRAn open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcersSurg Infect (Larchmt)20056274015865549
   PubMedGoogle Scholar
• TiceADTurpinRSHoeyCTComparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infectionsAm J Health Syst Pharm2007641080108617494908
   PubMed Web of Science ®Google Scholar
• BoselliEBreilhDDjabaroutiSBelJCSauxMCDiffusion of ertapenem into bone and synovial tissuesJ Antimicrob Chemother20076089389617704514
   PubMed Web of Science ®Google Scholar
• LaethemTDe LepeleireIMcCreaJTissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteersAntimicrob Agents Chemother2003471439144212654688
   PubMed Web of Science ®Google Scholar
• BurkhardtOBrunnerMSchmidtSPenetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysisJ Antimicrob Chemother20065863263616840426
   PubMed Web of Science ®Google Scholar
• VautheyLUçkayIAbrassartSVancomycin-induced DRESS syndrome in a female patientPharmacology20088213814118607115
   PubMed Web of Science ®Google Scholar
• CrucianiMLipskyBAMengoliCde LallaFGranulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infectionsCochrane Database Syst Rev2009Issue 3. Art. No. CD006810.
   PubMedGoogle Scholar
• HuntDFoot ulcers and amputations in diabetesBMJ Clinical Evidence2006URL http://www.clinicalevidence.com/ceweb/conditions/dia/0602/0602_I4.jsp
   Google Scholar
• GoldmanRJHyperbaric oxygen therapy for wound healing and limb salvage: a systematic reviewPMR20091471489
   PubMedGoogle Scholar
• LipskyBASheehanPArmstrongDGClinical predictors of treatment failure for diabetic foot infections: data from a prospective trialInt Wound J20074303817425547
   PubMedGoogle Scholar
• ArmstrongDGLipskyBADiabetic foot infections: stepwise medical and surgical managementInt Wound J2004112313216722884
   PubMedGoogle Scholar
• SennevilleELombartABeltrandEOutcome of diabetic foot osteomyelitis treated non-surgically: a retrospective cohort studyDiabetes Care2006463764216505519
   PubMedGoogle Scholar
• Hartemann-HeurtierASennevilleEDiabetic foot osteomyelitisDiabetes Metab200834879518242114
   PubMed Web of Science ®Google Scholar
• VekatesanPLawnSMacfarlaneRMConservative management of osteomyelitis in the feet of diabetic patientsDiabet Med1997144874909212316
   PubMedGoogle Scholar
• EmbilJMRoseGTrepmanEOral antimicrobial therapy for diabetic foot osteomyelitisFoot Ankle Int20062777177917054876
   PubMed Web of Science ®Google Scholar
• GameFLJeffcoateWJPrimarily non-surgical management of osteomyelitis of the foot in diabetesDiabetologia200851962967KapurNKMusunuruKClinical efficiency and safety of statins in managing cardiovascular riskVasc Health Risk Manag200842341353
   PubMedGoogle Scholar
  MeltzerPSKallioniemiATrentJMChromosome alterations in human solid tumorsVogelsteinBKinzlerKWThe Genetic Basis of Human CancerNew YorkMcGraw-Hill200293113
   Google Scholar